HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Temporary Prostate Stent Alleviates Bladder Obstruction

By HospiMedica International staff writers
Posted on 13 Jul 2016
Print article
Image: The Spanner temporary prostatic stent (Photo courtesy of SRS Medical).
Image: The Spanner temporary prostatic stent (Photo courtesy of SRS Medical).
A novel stent helps maintain urine flow and allow for voluntary urination in male patients experiencing lower urinary tract symptoms (LUTS).

The Spanner Temporary Prostatic Stent is an alternative to both indwelling Foley catheters and intermittent urinary catheters for male patients with bladder outlet obstruction (BOO). It consists of two anchors and a silicone tube designed to reduce resistance in the bladder neck and prostatic urethra, without stenting the external sphincter. The Spanner is placed blindly without anesthesia, similar to the placement of a Foley catheter, and is a completely internal device that allows patients to naturally fill and empty their bladders, often without device awareness.

Indications for use include relieving LUTS in patients in temporary urinary retention, including those recovering from surgical procedures; reducing infection risk and medical complication in patients awaiting procedures for benign prostatic hyperplasia (BPH); long-term symptom relief for patients unfit for prostate procedures; and as an aid in predicting BPH procedure outcomes in high-risk surgical candidates. The Spanner Temporary Prostatic Stent is a product of SRS Medical (Billerca, MA, USA), and has received by the European Community CE mark of approval.

“The Spanner is proven to have significant impact on medical outcomes, and often has a transformational impact on patient quality of life,” said Lee Brody, CEO of SRS Medical. “We are excited to receive this approval, and we look forward to working with our European partners to deliver The Spanner to the patients that will benefit from it the most.”

BPH is the most common cause of bladder outlet obstruction in men, causing a blockage that slows or stops urine flow out of the bladder. The urine can back up in the urinary system, leading to difficulty urinating and other uncomfortable urinary symptoms. Emergency treatment includes insertion of a catheter through the urethra and into the bladder to drain it.

Related Links:
SRS Medical


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Traumatic Brain Injury Whole Blood Test
i-STAT TBI CARTRIDGE

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more